Full-Time

Customer Marketing Manager

Oncology

Posted on 2/21/2026

Deadline 3/31/26
LabCorp

LabCorp

10,001+ employees

Global life sciences R&D services

No salary listed

Mumbai, Maharashtra, India + 1 more

More locations: Bengaluru, Karnataka, India

In Person

Category
Growth & Marketing (1)
Required Skills
Data Analysis
Requirements
  • 10+ years Marketing experience mandatory within healthcare / pharma industry
  • Experience in biopharmaceutical segment is desired
  • Bachelor’s degree in science.
  • Proven results with marketing program strategy, planning, development, and implementation through multi-channel approaches (digital, social, print, email, webinar and face-to-face events, etc.)
  • Knowledge of account-based marketing (ABM)
  • Deep expertise in channel strategy and channel optimization
  • Robust understanding of the target audience and the customer journey to enable strategic campaign design
  • Deep expertise in marketing automation, especially Eloqua, and working knowledge of customer relationship manager databases are a must.
  • Strong understanding of the digital marketing technology landscape, Artificial Intelligence platforms and best practices desirable
  • Strong communication, copywriting and editing skills needed
  • Proven results with marketing program strategy, planning, development, and implementation through omni-channel approaches (digital, social, print, email, webinar and face-to-face events, etc.) Working knowledge of account-based marketing (ABM), deep expertise in channel strategy and robust understanding of the target audience and the customer journey to enable strategic campaign design. Deep expertise in marketing automation a must.
  • Highly organized with strong project management and data analysis skills
  • Effective communicator
  • Able to work through a highly matrixed organization
  • Open to working across time zones
Responsibilities
  • Design, execute and optimize campaign plans that deliver on business objectives and ensure reach into target audience, and continued nurture and qualification of leads. Key responsibilities include:
  • Orchestrate delivery of campaign plans to ensure alignment with marketing plan
  • Manage campaign and annual marketing plan calendar & timelines
  • Lead tactic sequencing and prioritization, project management
  • Guide content strategy and messaging architecture across all marketing channels (media, web, email, sales, events, etc.)
  • Manage audience marketing budget spend (media, agencies, creative, etc.) appropriately by aligning tactical plans with P&S leadership’s strategic priorities
  • Aggregate and analyze campaign performance data and report on key performance indicators (KPIs) and insights to drive optimization and maximize campaign effectiveness
  • Manage third party vendors or in-house channel partners to execute on campaign plan, asset development and delivery
  • Collaborate with the Product Management and Product Marketing team to understand business goals and strategies, market sizing and product positioning.
  • Lead recurring meeting cadence with Product Marketing and other key stakeholders to ensure timely and on-target execution of campaigns
  • Work across organizational structures, within and beyond the marketing team, partnering with Sales, Medical Affairs, Science and operations to enable on-time and on—target delivery
  • Apply journey-development strategies in partnership with Product Management, Product Marketing, Science and Technology, Medical Affairs and Clinical Directors to target the right message to the right person at the right time
  • Enable delivery of the brand experience, voice, and visuals across all marketing channels

Labcorp provides end-to-end R&D services for life sciences and agricultural clients, including crop protection, with testing and regulatory support. It runs physicochemical analyses, safety assessments, and inhalation toxicology studies using specialized labs to evaluate inhaled substances. It differentiates itself with a global footprint and an integrated set of services across the product lifecycle, including regulatory submissions. Its goal is to help clients bring safe, effective products to market efficiently by applying rigorous science and scalable testing.

Company Size

10,001+

Company Stage

IPO

Headquarters

Burlington, Vermont

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $3.54B, up 5.8%, raising full-year guidance to $14.73B.
  • AI Alzheimer's platform validates spring 2026, expands to oncology and cardiometabolic areas.
  • Optum.ai partnership automates lab workflows and enhances patient engagement.

What critics are saying

  • Quest Diagnostics outgrows Labcorp at 9.2% versus 5.8%, eroding diagnostics share in 6-12 months.
  • NeoGenomics seizes oncology volume with 11.1% growth, hitting Labcorp's specialty testing now.
  • Tempus commoditizes Labcorp's AI platform with superior EHR integration in 24 months.

What makes LabCorp unique

  • Labcorp's AI platform with AWS and Datavant analyzes Alzheimer's data in minutes using deidentified lab datasets.
  • Labcorp holds first FDA clearance for rapid fentanyl urine test in emergency settings.
  • Labcorp's Plasma Detect Genome MRD assesses NSCLC recurrence risk via whole-genome sequencing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Tuition Reimbursement

Employee Stock Purchase Plan

Company News

360Dx
May 5th, 2026
Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC.

Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC. NEW YORK - Temple Health's Fox Chase Cancer Center and Laboratory Corporation of America announced Tuesday a clinical trial collaboration to evaluate the use of Labcorp's whole-genome sequencing Plasma Detect Genome MRD to assess the risk of recurrence in patients with early stage non-small cell lung cancer (NSCLC). Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

Resonate Group
Apr 15th, 2026
Labcorp launches rapid fentanyl test with 48-hour detection window.

Labcorp launches rapid fentanyl test with 48-hour detection window. * April 15, 2026 While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public health crisis in the U.S., and now Labcorp is launching a new test designed to detect the drug's use for up to 48 hours after exposure. Fields (*) Mark are Required

PR Newswire
Apr 14th, 2026
Labcorp launches AI-powered platform with AWS and Datavant to accelerate Alzheimer's research

Labcorp has launched an AI-powered real-world data platform to accelerate Alzheimer's disease research, developed in collaboration with Amazon Web Services and Datavant. The platform aims to generate insights in minutes that previously required months of data analysis. The system combines Labcorp's diagnostic and genomic datasets with medical claims data, using AWS AI services including Amazon Bedrock and Amazon SageMaker. It enables researchers to identify patient cohorts, track disease progression and measure treatment effectiveness across diverse populations using deidentified healthcare data. With over 7.2 million Americans living with Alzheimer's and annual care costs exceeding $380 billion in the US, the platform addresses traditional challenges of fragmented data and lengthy preparation times. Initial validation will complete in spring 2026, with plans to expand into inflammatory diseases, cardiometabolic conditions, women's health and oncology.

360Dx
Apr 13th, 2026
Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics.

Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics. NEW YORK - Laboratory Corporation of America and Children's Hospital of Philadelphia (CHOP) on Monday announced a strategic collaboration to accelerate the development of and access to specialized pediatric diagnostics. Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

360Dx
Mar 20th, 2026
In brief this week: Labcorp, guardant Health, waters, fulgent genetics, more.

In brief this week: Labcorp, guardant Health, waters, fulgent genetics, more. NEW YORK - Laboratory Corporation of America this week said it has completed its acquisition of select assets of Crouse Health's Laboratory Alliance of Central New York's laboratory business. The two firms also have entered into a deal for Crouse Health to manage the daily operations of its inpatient lab, while Labcorp will take over operations of the lab alliance's 12 patient service centers. It said in a statement that the deal will improve access to high-quality, affordable diagnostic services in Central New York by offering patients and providers Labcorp's expanded testing menu, data, and digital tools. To read the full story... What's Popular?

INACTIVE